Fol. Biol. 2006, 52, 194-201
https://doi.org/10.14712/fb2006052060194
Polymorphisms of Dopamine-β-Hydroxylase in ADHD Children
References
1. 1987) DSM-III-R disorders in preadolescent children: Prevalence in a large sample from the general population. Arch. Gen. Psychiatry 4, 69-76.
< , J. S., Williams, S., McGee, R., Silva, P. A. (https://doi.org/10.1001/archpsyc.1987.01800130081010>
2. 2005) Analysis of polymorphisms in the dopamine βhydroxylase gene: association with attention deficit hyperactivity disorder in Indian children. Indian Pediatr. 42, 123-129.
, N., Sinha, S., Chattopadhyay, A., Gangopadhyay, P. K., Singh, M., Mukhopadhyay, K. K. (
3. 1991) Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am. J. Psychiatry 148, 564-577.
, J., Newcorn, J., Sprich, S. (
4. 1988) Plasma dopamine-β-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder. J. Am. Acad. Child Adolesc. Psychiatry 27, 171-174.
< , C. L., Deutsch, C. K., Swanson, J. M. (https://doi.org/10.1097/00004583-198803000-00006>
5. 1996) Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: The additive and subtractive effect of the three dopaminergic genes – DRD2, D βH, and DAT1. Am. J. Med. Genet. Neuropsychiatr. Genet. 67, 264-288.
< , D. E., Wu, S., Chiu, C., Ring, R. H., Gade, R., Ahn, C., MacMurray, J. P., Dietz, G., Muhleman, D. (https://doi.org/10.1002/(SICI)1096-8628(19960531)67:3<264::AID-AJMG4>3.0.CO;2-N>
6. 1999) Additive effect of three noradrenergic genes (ADRA2A, ADRA2C, DBH) on attention deficit hyperactivity disorder and learning disabilities in Tourette syndrom subjects. Clin. Genet. 55, 160-172.
< , D. E., Gade Andavolu, R., Gonzales, N., Blake, H., Wu, S., MacMurray, J. P. (https://doi.org/10.1034/j.1399-0004.1999.550304.x>
7. 1988) Localization of the human dopamine β hydroxylase (DBH) gene to chromosome 9q34. Cytogenet. Cell Genet. 48, 48-50.
< , S. P., Buckle, V. J., Lamouroux, A., Mallet, J., Craig, I. W. (https://doi.org/10.1159/000132584>
8. 2004) Human genetics of plasma B-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology 174, 463-476.
< , J. F., Zabetian, C. P. (https://doi.org/10.1007/s00213-004-1840-8>
9. 1997) Population genetics of a functional variant of the dopamine β-hydroxylase gene (DBH). Am. J. Med. Genet. 74, 374-379.
< , J. F., Kobayashi, K., Nagatsu, T., Kidd, K. K., Kidd, J. R., Calafell, F., Kranzler, H. R., Ichinose, H., Gelernter J. (https://doi.org/10.1002/(SICI)1096-8628(19970725)74:4<374::AID-AJMG7>3.0.CO;2-P>
10. 1998) Dopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum. Genet. 102, 533-540.
< , J. F., van Kammen, D. P., Kelley, M. E., Anderson, G. M., O’Connor, D. T., Price, L. H., Malison, R., Rao, P. A., Kobayashi, K., Nagatsu, T., Gelernter, J. (https://doi.org/10.1007/s004390050736>
11. 2000) A haplotype at the DBH locus, associated with low plasma dopamine β-hydroxylase activity, also associates with cocaine-induced paranoia. Mol. Psychiatry 5, 56-63.
< , J. F., Kranzler, H. R., McCance-Katz, E., Anderson, G. M., Malison, R. T., Price, L. H., Gelernter, J. (https://doi.org/10.1038/sj.mp.4000657>
12. 1999) Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol. Psychiatry 4, 192-196.
< , G., Hawi, Z., Fitzgerald, M., Gill, M. (https://doi.org/10.1038/sj.mp.4000510>
13. 1976) Human serum dopamine β-hydroxylase: correlation of enzymatic activity with immunoreactive protein in genetically defined samples. Am. J. Hum. Genet. 28, 155-166.
, J., Weinshilboum, R. (
14. 1992) Segregation analysis of attention deficit hyperactivity disorder. Psychiatr. Genet. 2, 257-275.
< , S. V., Biederman, J., Chen, W. J., Krifcher, B., Keenan, K., Moore, C., Sprich, S., Tsuang, M. T. (https://doi.org/10.1097/00041444-199210000-00004>
15. 2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol. Psychiatry 57, 1313-1323.
< , S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., Sklar P. (https://doi.org/10.1016/j.biopsych.2004.11.024>
16. 1972) Changes in human serum dopamine-β-hydroxylase activity with age. Nature 236, 310-311.
< , L. S., Ohuchi, T., Goldstein, M., Axelrod, F., Fish, I., Dancis, J. (https://doi.org/10.1038/236310a0>
17. 1993) Biodevelopmental aspects of conduct disorder in boys. Child. Psych. Hum. Dev. 24, 125-141.
< , S., Stadler, J., Bjorn, J., Shindledecker, R., Bowden, C. L. (https://doi.org/10.1007/BF02367265>
18. 1995) Serum dopamine-β-hydroxylase and maltreatment in psychiatrically hospitalized boys. Child Abuse Negl. 19, 821-832.
< , M., TenEyck, R., Shekhar, A., Stilwell, B., Fineberg, N., Laite, G., Karwisch, G. (https://doi.org/10.1016/0145-2134(95)00042-7>
19. 1997) Maltreatment, conscience fuctioning and dopamine-β-hydroxylase in emotionally disturbed boys. Child Abuse Negl. 21, 83-92.
< , M., Stilwell, B. M., Shekhar, R., Kopta, S. M., Goldfarb, S. M. (https://doi.org/10.1016/S0145-2134(96)00128-7>
20. 2003) Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol. Psychiatry 8, 299-308.
< , Z., Lowe, N., Kirley, A., Gruenhage, F., Nothen, M., Greenwood, T., Kelsoe, J., Fitzgerald, M., Gill, M. (https://doi.org/10.1038/sj.mp.4001290>
21. 1995) Absence of linkage of apparently single gene mediated ADHD with the human syntenic region of the mouse mutant Coloboma. Am. J. Med. Genet. 60, 573-579.
< , E. J., Rogan, P. K., Domoto, M., Tinker, D. E., Ladda, R. L., Ramer, J. C. (https://doi.org/10.1002/ajmg.1320600619>
22. 1994) Cell-specific expression from the human dopamine β-hydroxylase promoter in transgenic mice is controlled via a combination of positive and negative regulatory elements. J. Neurosci. 14, 2455-2463.
< , G. W., Mercer, E. H., Palmiter, R. D., Brinster, R. L. (https://doi.org/10.1523/JNEUROSCI.14-05-02455.1994>
23. 2004) Linkage disequilibrium analysis of the dopamine β-hydroxylase gene in persistent attention deficit hyperactivity disorder. Psychiatr. Genet. 14, 117-120.
< , B., Muglia, P., Jain, U., Kennedy, J. L. (https://doi.org/10.1097/01.ypg.0000107932.32051.1c>
24. 1993) Neuron-specific expression of the human dopamine β-hydroxylase gene requires both the cAMP-response element and a silencer region. J. Biol. Chem. 268, 17987-17994.
< , H., Kim, K. T., Joh, T. H., Kim, K. S. (https://doi.org/10.1016/S0021-9258(17)46802-5>
25. 1991) Expression of two forms of human dopamine-β-hydroxylase in COS cells. Neurosci. Lett. 125, 25-28.
< , A., Kobayashi, K., Kiuchi, K., Nagatsu, T. (https://doi.org/10.1016/0304-3940(91)90121-9>
26. 1997) Comorbidity in ADHD: Implications for research, practice and DSM-IV. J. Am. Acad. Child Adolesc. Psychiatry 36, 1065-1079.
< , P. S., Martin, B. A., Cantwell, D. P. (https://doi.org/10.1097/00004583-199708000-00014>
27. 1998) Noradrenergic-specific transcription of the dopamine β-hydroxylase gene requires synergy of multiple cis-acting elements including at least two Phox2a-binding sites. J. Neurosci. 18, 8247-8260.
< , H. S., Seo, H., Yang, C., Brunet, J. F., Kim, K. S. (https://doi.org/10.1523/JNEUROSCI.18-20-08247.1998>
28. 2002) Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology 27, 607-619.
, A., Hawi, Z., Daly, G., McCarron, M., Mullins, C., Millar, N., Waldman, I., Fitzgerald, M., Gill, M. (
29. 1989) Human dopamine β-hydroxylase gene: two mRNA types having different 3’-terminal regions are produced through alternative polyadenylation. Nucleic Acids Res. 17, 1089-1102.
< , K., Kurosawa, Y., Fujita, K., Nagatsu, T. (https://doi.org/10.1093/nar/17.3.1089>
30. Koudelová, J., Paclt, I., Mourek, J., Trojan, S. (1989) Variability in dopamin-βhydroxylase activity in plasma of rats (the effect of age and of hypoxia in plasma of children with mental disorders). In: Van Loun, C. R., Kvetňanský, K., McCarthy, R. and Axelrod, J., Eds. Stress: Neurochemical and Humoral Mechanismus. New York: Gordon and Break Science Publishers, S. A. pp. 967-974.
31. 1997) Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J. Am. Acad. Child Adolesc. Psychiatry 36, 737-744.
< , F., Hay, D. A., McStephen, M., Wood, C., Waldman, I. (https://doi.org/10.1097/00004583-199706000-00009>
32. 1992) Dopamine and the neural circuitry of primate prefrontal cortex: implications for schizophrenia research. Neuropsychopharmacology 6, 127-134.
, D. A., Hayes, T. L., Lund, J. S., Oeth, K. M. (
33. 1983) Homologous radio-immunoassay of human plasma dopamine-β-hydroxylase: analysis of homospecific activity, circulating plasma pool and intergroup differences based on race, blood pressure and cardiac function. J. Hypertens. 1, 227-233.
< , D. T., Levine, G. L., Frigon, R. P. (https://doi.org/10.1097/00004872-198310000-00006>
34. 1994) Dopamine β-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson’s disease and congenital dopamine β-hydroxylase deficiency. Clin. Sci. 86, 149-158.
< , D. T., Cervenka, J. H., Stone, R. A., Levine, G. L., Parmer, R. J., Franco-Bourland, R. E., Madrazo, I., Langlais, J., Robertson, D., Biaggioni, I. (https://doi.org/10.1042/cs0860149>
35. 1986) Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals-a genetic study. J. Psychiatr. Res. 20, 19-29.
< , G., Edman, G., Iselius, L., Oreland, L., Ross, S. B., Sedvall, G. (https://doi.org/10.1016/0022-3956(86)90020-8>
36. 1990) Dopamine-β-hydroxylase in plasma of psychiatric patients. Activ. Nerv. Super. 32, 67.
, I., Koudelová, J. (
37. 2004) Changes of dopamine-β-hydroxylase activity during ontogenesis in healthy subjects and in an experimental model (rats). Physiol. Res. 53, 661-667.
, I., Koudelova, J. (
38. 2001) Genetics of childhood disorders: XXIII. ADHD, Part 7: The serotonin system. J. Am. Acad. Child. Adolesc. Psychiatry 40, 253-257.
< , J. S., Kennedy, J. L. (https://doi.org/10.1097/00004583-200102000-00022>
39. 1966) Diethyldithiocarbamate and amphetamine stereotype behavior. J. Pharm. Pharmacol. 18, 752.
< , A., Scheel-Kruger, J. (https://doi.org/10.1111/j.2042-7158.1966.tb07799.x>
40. 1989a) Plasma dopamine-β-hydroxylase and preschool behaviour in children with conduct disorder. Child Psychiatry Hum. Dev. 20, 149-156.
< , G. A., Crawford, L., McNamara, A. (https://doi.org/10.1007/BF00711661>
41. 1989b) Attention deficit disorder symptoms and urine catecholamines. Psychiatry Res. 27, 241-251.
< , G. A., Maas, J. W., Javors, M. A., Macedo, C. A., Fischer, C., Harris, W. R. (https://doi.org/10.1016/0165-1781(89)90140-6>
42. 2002) Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-β-hydroxylase gene. Am. J. Med. Genet. 114, 154-158.
< , T., Schmitz, M., Polanczyk, G. V., Eizirik, M., Rohde, L. A., Hutz, M. H. (https://doi.org/10.1002/ajmg.10194>
43. 1983) Urinary MHPG and HVA excretion in boys with attention deficit hyperactivity disorder and hyperactivity treated with d-amphetamine. Biol. Psychiatry 18, 707-714.
, W. O., Javaid, J., Davis, J.M., Bylund, D. B. (
44. 2003) Association of the dopamine βhydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 119, 77-85.
< , K. M., Daly, M., Fischer, M., Yiannoutsos, C. T., Bauer, L., Barkley, R., Navia, A. (https://doi.org/10.1002/ajmg.b.20005>
45. 1990) Developmental change of dopamine β-hydroxylase activity in cerebrospinal fluid of epileptic and non-epileptic children. J. Neural. Transm. Gen. Sect. 80, 225-230.
< , H., Shimohira, M., Iwakawa, Y., Nagatsu, T. (https://doi.org/10.1007/BF01245124>
46. 2005) Haplotype-controlled analysis of the association of a non-synonymous single nucleotide polymorphism at DBH (+ 1603C —> T) with plasma dopamine β-hydroxylase activity. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 139, 88-90.
< , Y., Anderson, G. M., Zabetian, C. P., Kohnke, M. D., Cubells, J. F. (https://doi.org/10.1002/ajmg.b.30220>
47. 1998) Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J. Child Psychol. Psychiatry 39, 65-99.
< , R. (https://doi.org/10.1111/1469-7610.00304>
48. 1998) Association and linkage of the dopamine transporter gene and attentiondeficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet. 63, 1767-1776.
< , I. D., Rowe, D. C., Abramowitz, A., Kozel, S. T., Mohr, J. H., Sherman, S. L., Cleveland, H. H., Sanders, M. L., Gard, J. M., Stever, C. (https://doi.org/10.1086/302132>
49. 1997) Possible control of dopamine β-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum. Genet. 99, 52-55.
< , J., Ramchand, C. N., Hemmings, G. P. (https://doi.org/10.1007/s004390050310>
50. 1978) Serum dopamine β-hydroxylase. Pharmacol. Rev. 30, 133-166.
, R. M. (
51. 1971) Serum dopamine-β-hydroxylase: decrease after chemical sympathectomy. Science 173, 931-934.
< , R., Axelrod, J. (https://doi.org/10.1126/science.173.4000.931>
52. 1973) Serum dopamine-β-hydroxylase activity: sibling-sibling correlation. Science 181, 943-945.
< , R. M., Raymond, F. A., Elveback, L. R., Weidman, W. H. (https://doi.org/10.1126/science.181.4103.943>
53. 2002) Attention deficit hyperactivity disorder and the gene for dopamine β-hydroxylase. Am. J. Psychiatry 159, 1046-1048.
< , K., Zai, G., Schachar, R., Tannock, R., Roberts, W., Malone, M., Kennedy, J. L., Barr, C. L. (https://doi.org/10.1176/appi.ajp.159.6.1046>
54. 1998) Measurement of serum catecholamines in boys with attention deficit hyperactivity disorder. Chinese J. Psychiatry 31, 30-33.
, D., Linyan, S., Xuerong, L. (
55. 2001) A quantitative-trait analysis of human plasma-dopamine β-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am. J. Hum. Genet. 68, 515-522.
< , C. P., Anderson, G. M., Buxbaum, S. G., Elston, R. C., Ichinose, H., Nagatsu, T., Kim, K. S., Kim, C. H., Malison, R. T., Gelernter, J., Cubells, J. F. (https://doi.org/10.1086/318198>
56. 2003) The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine β-hydroxylase activity. Am. J. Hum. Genet. 72, 1389-1400.
< , C. P., Buxbaum, S. G., Elston, R. C., Kohnke, M. D., Anderson, G. M., Gelernter, J., Cubells, J. F. (https://doi.org/10.1086/375499>
57. 2004) Association of dopamine β-hydroxylase polymorphism with attention deficit hyperactivity disorder in children. [in Chinese] Beijing Da Xue Xue Bao 36, 290-293.
, H. B., Wang, Y. F., Li, J., Wang, B., Yang, L. (
58. 1976) Plasma noradrenaline increases with age. Nature 261, 333-335.
< , M. G., Lake, C. R., Kopin, I. J. (https://doi.org/10.1038/261333a0>